# Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma

> **NCT01887340** · PHASE2 · RECRUITING · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 271 (estimated)

## Conditions studied

- Seminoma

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Etoposide
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT01887340
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2013-06
- **Primary completion:** 2016-06
- **Final completion:** 2026-06
- **Target enrollment:** 271 (ESTIMATED)
- **Last updated:** 2016-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01887340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01887340, "Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01887340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*